Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$357M |
| 2 |
NVIDIA
NVDA
|
+$317M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Trip.com Group
TCOM
|
+$192M |
| 5 |
Petrobras
PBR
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Markel Group
MKL
|
+$299M |
| 2 |
Dolby
DLB
|
+$256M |
| 3 |
JD.com
JD
|
+$128M |
| 4 |
Amazon
AMZN
|
+$117M |
| 5 |
Baidu
BIDU
|
+$83.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.93% |
| 2 | Communication Services | 18.08% |
| 3 | Healthcare | 12.56% |
| 4 | Technology | 9.19% |
| 5 | Financials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
TripAdvisor
TRIP
$1.65B
| $576M | 0.95% |
12,417,263
-211,132
| -2% | -$11.6M |
|
27
EOG Resources
EOG
$79.2B
| $551M | 0.91% |
5,453,226
-138,269
| -2% | -$13.5M |
|
28
Workday
WDAY
$39.6B
| $519M | 0.85% |
7,854,613
-30,336
| -0.4% | -$2.44M |
|
|
29
Markel Group
MKL
$23.3B
| $515M | 0.85% |
569,135
-334,864
| -37% | -$299M |
|
30
Visa
V
$684B
| $513M | 0.84% |
6,572,440
-205,095
| -3% | -$16.5M |
|
31
APA Corp
APA
$13.2B
| $512M | 0.84% |
8,060,349
-185,989
| -2% | -$11.7M |
|
32
Under Armour
UAA
$2.84B
| $509M | 0.84% |
17,535,907
+3,335,020
| +23% | +$109M |
|
33
Salesforce
CRM
$151B
| $474M | 0.78% |
6,919,332
-158,343
| -2% | -$11.5M |
|
|
NBIS
34
Nebius Group N.V.
NBIS
$48.3B
| $457M | 0.75% |
22,702,677
-548,282
| -2% | -$10.8M |
|
|
35
JD.com
JD
$44.6B
| $442M | 0.73% |
17,384,889
-4,930,505
| -22% | -$128M |
|
36
Teradyne
TER
$57.6B
| $422M | 0.69% |
16,622,390
-344,177
| -2% | -$8.16M |
|
37
C.H. Robinson
CHRW
$17.4B
| $416M | 0.68% |
5,675,710
-56,596
| -1% | -$4.09M |
|
38
Waters Corp
WAT
$37B
| $412M | 0.68% |
3,064,158
-75,767
| -2% | -$10.8M |
|
|
39
Verisk Analytics
VRSK
$25.4B
| $405M | 0.67% |
4,988,166
+4,350,014
| +682% | +$357M |
|
40
RB Global
RBA
$20.4B
| $405M | 0.67% |
11,899,567
-282,659
| -2% | -$10.3M |
|
41
Ionis Pharmaceuticals
IONS
$8.6B
| $402M | 0.66% |
8,415,156
-60,191
| -0.7% | -$2.38M |
|
42
Lincoln Electric
LECO
$14.2B
| $397M | 0.65% |
5,173,755
-86,145
| -2% | -$6.17M |
|
43
Wabtec
WAB
$49.1B
| $395M | 0.65% |
4,762,036
-119,520
| -2% | -$9.85M |
|
44
MarketAxess Holdings
MKTX
$5.71B
| $390M | 0.64% |
2,657,408
-21,040
| -0.8% | -$3.34M |
|
45
DexCom
DXCM
$31.5B
| $366M | 0.6% |
24,515,216
+178,968
| +0.7% | +$3.17M |
|
46
Colgate-Palmolive
CL
$73.1B
| $355M | 0.58% |
5,418,509
-355,161
| -6% | -$24.4M |
|
|
SPLK
47
DELISTED
Splunk Inc
SPLK
| $349M | 0.57% |
6,816,533
-68,422
| -1% | -$3.94M |
|
48
New Oriental
EDU
$9.37B
| $339M | 0.56% |
8,057,783
-139,869
| -2% | -$6.59M |
|
|
BLUE
49
DELISTED
bluebird bio
BLUE
| $319M | 0.52% |
398,697
+12,787
| +3% | +$10.2M |
|
50
ResMed
RMD
$30.6B
| $313M | 0.52% |
5,049,184
-101,586
| -2% | -$6.22M |
|
Similar funds
Baillie Gifford & Co's Q4 2016 Portfolio in Review
As of Q4 2016, Baillie Gifford & Co held 203 positions worth $60.8B, down 4.9% from $63.9B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Baillie Gifford & Co's Q4 2016 filing shows 8 new, 65 increased, 89 reduced and 5 closed positions. Its largest new stake was Petrobras: 12,394,510 shares worth $125M. The largest sale was Markel Group, an estimated $299M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q4 2016 buy was Petrobras: 12,394,510 shares worth $125M.
- Baillie Gifford & Co added most to Verisk Analytics in Q4 2016, an estimated $357M increase.
- Baillie Gifford & Co's biggest Q4 2016 reduction was Markel Group, cutting an estimated $299M.
- Baillie Gifford & Co fully exited Televisa in Q4 2016, selling an estimated $57.7M.
- Baillie Gifford & Co's ten largest holdings make up 48% of its $60.8B portfolio in Q4 2016.
- Baillie Gifford & Co opened 8 new positions and closed 5 in Q4 2016.
- Baillie Gifford & Co's portfolio value fell 4.9% quarter-over-quarter to $60.8B.
Based on Baillie Gifford & Co's 13F filing for Q4 2016, filed 14 Feb 2017.